文献速递消化道肿瘤与早癌消化内镜

基于CT结肠成像监测和内镜下切除的小(6-9 mm)结直肠息肉的生长速率与组织病理学结局

Growth rates and histopathological outcomes of small (6-9 mm) colorectal polyps based on CT colonography surveillance and endoscopic removal.
PubMed 文献 · Gut · 2023-11-24

本研究基于16.4年11 165例无症状CT结肠成像筛查患者,分析314例立即息肉切除和382例CT结肠成像监测(平均4.7年)的6-9 mm息肉。监测组中24.9%息肉生长、62.0%稳定、13.1%缩小;生长息肉切除后进展组织学风险高于稳定/缩小息肉(OR 4.0),快速生长者风险更高(OR 25.4)。

要点

  • 6-9 mm息肉多数稳定或缩小(75%),进展组织学仅7%。
  • 生长息肉进展组织学风险为稳定/缩小息肉的4倍(OR 4.0)。
  • 快速生长息肉进展组织学风险更高(OR 25.4)。

核心结论

  • 6-9 mm小息肉总体风险低,息肉生长与更高风险病变强相关。
  • 多数(75%)6-9 mm小息肉稳定或缩小,仅7%出现进展组织学。
  • 少数(25%)生长的小息肉进展组织学风险增加3倍。

研究设计与样本

  • 研究纳入16.4年间11 165例无症状CT结肠成像筛查患者。
  • 1067例检出1或2枚6-9 mm息肉(无≥10 mm息肉)。
  • 314例(平均年龄57.4岁;男:女141:173;共375枚息肉)选择立即结肠镜息肉切除。
  • 382例(平均年龄57.0岁;男:女217:165;共481枚息肉)选择CT结肠成像监测,平均4.7年。
  • 分析息肉体积生长,并对切除息肉进行组织病理学关联。

主要发现

  • 立即切除组67.8%(213/314)为腺瘤,2.2%(7/314)有进展组织学;无癌或高级别异型增生。
  • 监测组24.9%(95/382)息肉生长,62.0%(237/382)稳定,13.1%(50/382)缩小。
  • 监测组58.6%(224/382)最终行结肠镜切除,其中87.1%(195/224)为腺瘤,12.9%(29/224)有进展组织学。
  • 生长息肉切除者进展组织学23.2%(19/82) vs 稳定/缩小息肉7.0%(10/142)(OR 4.0;p<0.001)。
  • 快速生长息肉进展组织学63.6%(14/22)(OR 25.4;p<0.001)。

关键数值与推荐

  • 息肉生长定义为每年体积变化±20%,快速生长定义为每年+100%(年体积倍增)。
  • 进展组织学定义为存在癌、高级别异型增生(HGD)或绒毛成分。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The natural history of small polyps is not well established and rests on limited evidence from barium enema studies decades ago. Patients with one or two small polyps (6-9 mm) at screening CT colonography (CTC) are offered CTC surveillance at 3 years but may elect immediate colonoscopy. This practice allows direct observation of the growth of subcentimetre polyps, with histopathological correlation in patients undergoing subsequent polypectomy. DESIGN: Of 11 165 asymptomatic patients screened by CTC over a period of 16.4 years, 1067 had one or two 6-9 mm polyps detected (with no polyps ≥10 mm). Of these, 314 (mean age, 57.4 years; M:F, 141:173; 375 total polyps) elected immediate colonoscopic polypectomy, and 382 (mean age 57.0 years; M:F, 217:165; 481 total polyps) elected CTC surveillance over a mean of 4.7 years. Volumetric polyp growth was analysed, with histopathological correlation for resected polyps. Polyp growth and regression were defined as volume change of ±20% per year, with rapid growth defined as +100% per year (annual volume doubling). Regression analysis was performed to evaluate predictors of advanced histology, defined as the presence of cancer, high-grade dysplasia (HGD) or villous components. RESULTS: Of the 314 patients who underwent immediate polypectomy, 67.8% (213/314) harboured adenomas, 2.2% (7/314) with advanced histology; no polyps contained cancer or HGD. Of 382 patients who underwent CTC surveillance, 24.9% (95/382) had polyps that grew, while 62.0% (237/382) remained stable and 13.1% (50/382) regressed in size. Of the 58.6% (224/382) CTC surveillance patients who ultimately underwent colonoscopic resection, 87.1% (195/224) harboured adenomas, 12.9% (29/224) with advanced histology. Of CTC surveillance patients with growing polyps who underwent resection, 23.2% (19/82) harboured advanced histology vs 7.0% (10/142) with stable or regressing polyps (OR: 4.0; p<0.001), with even greater risk of advanced histology in those with rapid growth (63.6%, 14/22, OR: 25.4; p<0.001). Polyp growth, but not patient age/sex or polyp morphology/location were significant predictors of advanced histology. CONCLUSION: Small 6-9 mm polyps present overall low risk to patients, with polyp growth strongly associated with higher risk lesions. Most patients (75%) with small 6-9 mm polyps will see polyp stability or regression, with advanced histology seen in only 7%. The minority of patients (25%) with small polyps that do grow have a 3-fold increased risk of advanced histology.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Pooler BD, Kim DH, Matkowskyj KA, et al. Growth rates and histopathological outcomes of small (6-9 mm) colorectal polyps based on CT colonography surveillance and endoscopic removal. Gut. 2023. PMID: 37507217. doi:10.1136/gutjnl-2022-326970

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。